Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) [NA]
This clinical trial update describes a study evaluating liquid biopsy to detect AXL-positive circulating tumor cells in pancreatic ductal ad…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
A French study (FRENCH.MRD.PDAC) is evaluating minimal residual disease by liquid biopsies, including ctDNA, in patients with resectable pan…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Plasma Biomarkers P-DAC, V1
Update on a terminated clinical trial (P-DAC, V1) evaluating plasma biomarkers for pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: OSCAR I STUDY - The ONCObind CTC Removal Study [NA]
The OSCAR I study evaluating the ONCObind CTC removal system for pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment [Phase 2]
This is a Phase 2 clinical trial update for PANORAMIX, examining optimization of first-line NALIRIFOX (liposomal irinotecan-based therapy) a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: DC Vaccine in Pancreatic Cancer [Phase 1]
This Phase 1 trial update shows a completed study of a dendritic cell vaccine in pancreatic ductal adenocarcinoma, sponsored by the Universi…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: CART-meso in Mesothelin Expressing Cancers [Phase 1]
Phase 1 update on CART-meso, a mesothelin-targeted CAR T-cell therapy, tested in mesothelin-expressing cancers including metastatic pancreat…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating Icaritin in combination with AG for previously untreated advanced pancreatic ductal adenocarcinoma an…
-
CLINICAL_TRIALS other · 2025-06-25Clinical Trial Update: FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) [Phase 1]
A Phase 1 dose-escalation trial of Lu-177-labeled PNT6555 (FRONTIER) for selected solid tumors assessing safety, tolerability and dosimetry;…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial
Prospective cohort in Rouen evaluating six cycles of neoadjuvant modified FOLFIRINOX for potentially resectable pancreatic ductal adenocarci…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy [NA]
Ongoing clinical trial assessing predictive risk factors for pancreatic fistula after pancreaticoduodenectomy in patients with pancreatic or…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of DCTY1102 Injection in patients with advanced solid tumors, including pancreatic ductal adenocarcinoma, colorectal cancer, n…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies [NA]
Clinical trial update for 177Lu-CTR-FAPI in advanced metastatic digestive cancers; the study is not yet recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-06-06Clinical Trial Update: Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC [Phase 1, Phase 2]
Lisata Therapeutics reports that the Phase 1b/2a continuous infusion trial of ceretpetide in pancreatic ductal adenocarcinoma has been withd…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 2]
Phase 2 clinical trial evaluating the combination of nalirifoX (nanoliposomal irinotecan) with radiation therapy for pancreatic ductal adeno…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]
A Phase 1 clinical trial update describing the safety/tolerability study of SX-682 with nivolumab as maintenance therapy for metastatic panc…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]
This update reports completion of a Phase 1 trial evaluating a triple combination of MEK, STAT3, and PD-1 pathway inhibition in metastatic p…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals [EARLY_Phase 1]
This early-phase screening trial is evaluating prospective screening for pancreatic ductal adenocarcinoma in individuals at high risk.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) [Phase 2]
Phase 2 study evaluating NIS793 with or without spartalizumab in combination with standard-of-care chemotherapy for first-line metastatic pa…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: DDP ip Combined With AG in PDAC With Peritoneal Metastasis [Phase 2]
This is a completed Phase 2 trial evaluating intraperitoneal cisplatin (DDP ip) combined with AG in pancreatic ductal adenocarcinoma with pe…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: EUS-RFA PANCARDINAL-1 Trial [Phase 2]
Phase 2 trial update on endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for pancreatic ductal adenocarcinoma is currently rec…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Ketamine-assisted Therapy for Advanced GI Cancer [Phase 4]
Phase 4 trial evaluating ketamine-assisted therapy for advanced pancreatic ductal adenocarcinoma, focusing on cancer-related pain and demora…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China [Phase 1]
The Phase 1 study of JAB-3312 in adults with advanced solid tumors in China has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
This update describes a completed trial evaluating surgical approaches for pancreatic ductal adenocarcinoma with synchronous liver metastase…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery [NA]
This clinical trial aims to evaluate high-volume washing of the abdomen during surgery to improve survival in patients with resectable pancr…